医学
易普利姆玛
胆囊癌
无容量
胃肠病学
内科学
毒性
临床终点
进行性疾病
癌症
胆囊
临床研究阶段
外科
化疗
免疫疗法
临床试验
作者
Sandip Pravin Patel,Elizabeth Guadarrama,Young Kwang Chae,Michael J. Dennis,Benjamin Powers,Chih‐Yi Liao,William Ferri,Thomas J. George,Elad Sharon,Christopher W. Ryan,Megan Othus,G. López,Charles D. Blanke,Razelle Kurzrock
出处
期刊:Cancer
[Wiley]
日期:2024-02-15
卷期号:130 (17): 2918-2927
被引量:6
摘要
Most patients with advanced gallbladder cancer are treated with multiagent chemotherapy. Immune checkpoint inhibitors offer the possibility of a durable response with less toxicity. This prospective, multicenter, open-label study was designed to evaluate the anticancer activity of nivolumab plus ipilimumab in patients with advanced gallbladder cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI